STOCK TITAN
  1. Home
  2. Financials
  3. INM
  4. EPS (Diluted)

InMed Pharmaceuticals Inc. (INM) EPS by Year

INM

InMed Pharmaceuticals Inc. lost $3.12 per diluted share in fiscal year 2026. The table below carries 7 fiscal years, from 2020 to 2026, and the quarters InMed Pharmaceuticals Inc. has filed alongside them.

FY2026 annual
EPS (Diluted) -$3.12
Source SEC Filings (10-K/10-Q) Latest period FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

INM EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY26S-4/AFY25S-4FY24S-4FY2310-KFY2210-KFY2110-KFY2010-K
EPS (Diluted)-$3.12-$8.36-$20.14-$3.25-$33.17-$37.96N/A

INM EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'26S-4/AQ3'26S-4Q2'2610-QQ1'2610-QQ4'25S-4/AQ3'2510-QQ2'2510-QQ1'2510-QQ4'24S-4Q3'2410-QQ2'2410-QQ1'2410-Q
EPS (Diluted)-$1.43-$0.73-$0.51-$0.44-$0.43-$1.94-$3.64-$2.71-$3.66-$3.58-$3.71-$15.24

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More InMed Pharmaceuticals Inc. financials

Frequently Asked Questions

What was InMed Pharmaceuticals Inc.'s diluted earnings per share in fiscal year 2026?

InMed Pharmaceuticals Inc. lost $3.12 per diluted share in fiscal year 2026.

What was InMed Pharmaceuticals Inc.'s diluted earnings per share in the most recent quarter?

InMed Pharmaceuticals Inc. (INM) reported -$1.43 in diluted earnings per share in Q4 2026.

What does diluted earnings per share mean on a financial statement?

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what InMed Pharmaceuticals Inc. (INM) reported on that line in every period on record.